ViaLase
Aliso Viejo, US · Founded 2019 · Delaware corporation · 34 employees on LinkedIn · 2 known investors
ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma. The technology, used via its FLigHT procedure, is aimed at ophthalmic surgeons treating glaucoma without incisional surgery.
Founders & leadership
ViaLase was founded in 2019 by Tibor Juhasz.
TJ
Tibor JuhaszinFounder · Chief Executive Officer
RL
Rick LewisExecutive
SC
Scott CooperExecutive
HS
Hadi SrassinChief Operating Officer
SO
Shawn O'NeilinChief Executive Officer
Board
WL
JA
Jim AdoxBoard director
TP
FL
Franck LeveillerBoard director
TF
Tom FrinziBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$84.1M disclosed across 4 rounds · 2019–2024
▶$45.2MraisedSep 2024 · 15 investors · Other Health CareRule 506(b)
▶$45.2MraisedSep 2024 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Franck LeveillerDirector
- Tom FrinziDirector
- William LinkDirector
- Jim AdoxDirector
- Rick LewisExecutive Officer
- Tim PetersenDirector
- Scott CooperExecutive Officer
- Hadi SrassExecutive Officer
- Shawn O'NeilExecutive Officer
- Tibor JuhaszExecutive Officer, Director
- Offering amount
- $45.2M
- Amount sold
- $45.2M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3.5MraisedMar 2024 · 3 investors · Other Health CareRule 506(b)
▶$3.5MraisedMar 2024 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jim AdoxDirector
- Scott CooperExecutive Officer
- Rick LewisExecutive Officer
- Hadi SrassExecutive Officer
- Tim PetersenDirector
- Shawn O'NeilExecutive Officer
- Tibor JuhaszExecutive Officer, Director
- William LinkDirector
- Tom FrinziDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$27.3MraisedNov 2021 · 25 investors · Other Health CareRule 506(b)
▶$27.3MraisedNov 2021 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William LinkDirector
- Tim PetersenDirector
- Tibor JuhaszExecutive Officer, Director
- Jim AdoxDirector
- Offering amount
- $27.3M
- Amount sold
- $27.3M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$8.1MraisedApr 2019 · 7 investors · Other Health CareRule 506(b)
▶$8.1MraisedApr 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tim PetersenDirector
- William LinkDirector
- James AdoxDirector
- Tibor JuhaszExecutive Officer, Director
- Offering amount
- $8.1M
- Amount sold
- $8.1M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Lumenis6 shared keywordsLumenis develops and commercializes energy-based medical devices for the aesthetics and vision markets, serving healthcare professionals worldwide. The company holds over 330 patents and numerous FDA clearances, with an installed base of more than 80,000 systems across over 100 countries.
Cartessa Aesthetics5 shared keywordsCartessa Aesthetics sources and distributes aesthetic medical devices from leading global manufacturers to dermatologists, plastic surgeons, and medical spas in the U.S. and Canada. The company vets devices based on clinical efficacy, patient experience, and return on investment, positioning itself as an alternative to traditional aesthetic device distributors.
Evolus4 shared keywordsEvolus is an aesthetics company that markets Jeuveau, an injectable neurotoxin treatment offered through providers, along with a membership program (Club Evolus) for consumers. It operates in the medical aesthetics and pharmaceutical products space.
ELIOS Vision3 shared keywordsImplant-free, minimally invasive glaucoma surgery (MIGS) creating microscopic channels in the eye to lower intraocular pressure.
Companies competing with ViaLase for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ViaLase do?
- ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma. The technology, used via its FLigHT procedure, is aimed at ophthalmic surgeons treating glaucoma without incisional surgery.
- Who founded ViaLase?
- ViaLase was founded by Tibor Juhasz in 2019.
- Who are ViaLase's investors?
- ViaLase's investors include Arboretum Ventures, Versant Venture AIV Holdings.
- How much funding has ViaLase raised?
- ViaLase has disclosed $84.1M raised across 4 rounds.
- Where is ViaLase headquartered?
- ViaLase is headquartered in Aliso Viejo, US.